Carlo Zanon

6.8k total citations · 1 hit paper
39 papers, 2.3k citations indexed

About

Carlo Zanon is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Carlo Zanon has authored 39 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Carlo Zanon's work include Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Carlo Zanon is often cited by papers focused on Neuroblastoma Research and Treatments (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Carlo Zanon collaborates with scholars based in Italy, United States and Netherlands. Carlo Zanon's co-authors include Alberto Bardelli, Silvia Benvenuti, Andrea Sartore‐Bianchi, Silvio Veronese, Federica Di Nicolantonio, Mauro Moroni, Salvatore Siena, Simona Lamba, Sieger Leenstra and Fonnet E. Bleeker and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Carlo Zanon

39 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies

2007 672 citations Silvia Benvenuti, Carlo Zanon et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlo Zanon Italy	22	1.0k	959	524	464	407	39	2.3k
Dido Lenze Germany	29	1.2k 1.1×	671 0.7×	654 1.2×	387 0.8×	498 1.2×	80	2.3k
Cristina E. Tognon United States	26	2.0k 2.0×	980 1.0×	705 1.3×	509 1.1×	404 1.0×	81	3.6k
Kenji Tamura Japan	29	1.0k 1.0×	603 0.6×	701 1.3×	538 1.2×	198 0.5×	98	2.2k
Rainer Lehtonen Finland	26	907 0.9×	386 0.4×	569 1.1×	357 0.8×	276 0.7×	69	2.3k
Stacy W. Blain United States	18	2.5k 2.5×	1.4k 1.4×	463 0.9×	405 0.9×	326 0.8×	29	3.4k
Mark A. Pershouse United States	15	2.4k 2.3×	615 0.6×	487 0.9×	330 0.7×	433 1.1×	33	3.1k
Yotam Drier Israel	14	1.9k 1.8×	372 0.4×	558 1.1×	262 0.6×	224 0.6×	29	2.4k
Virginie Raynal France	26	1.1k 1.1×	562 0.6×	688 1.3×	295 0.6×	192 0.5×	40	2.3k
Julie Koeman United States	20	923 0.9×	365 0.4×	462 0.9×	286 0.6×	173 0.4×	26	1.5k
Chris Haqq United States	16	1.2k 1.2×	379 0.4×	640 1.2×	171 0.4×	332 0.8×	23	1.9k

Countries citing papers authored by Carlo Zanon

Since Specialization

Citations

This map shows the geographic impact of Carlo Zanon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Zanon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Zanon more than expected).

Fields of papers citing papers by Carlo Zanon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Zanon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Zanon. The network helps show where Carlo Zanon may publish in the future.

Co-authorship network of co-authors of Carlo Zanon

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Zanon. A scholar is included among the top collaborators of Carlo Zanon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Zanon. Carlo Zanon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Agostino, Stefania, Lucia Tombolan, Carlo Zanon, et al.. (2023). A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features. Scientific Reports. 13(1). 9444–9444. 5 indexed citations

Abdallah, Ali T., Carlo Zanon, Michael Vogt, et al.. (2023). 3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model. Materials Today Bio. 19. 100596–100596. 3 indexed citations

Corallo, Diana, Carlo Zanon, Gian Paolo Tonini, et al.. (2021). Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study. Cells. 10(10). 2695–2695. 2 indexed citations

Barbieri, Raffaella, Davide Cangelosi, Carlo Zanon, et al.. (2020). MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment. Biomedicines. 8(11). 471–471. 8 indexed citations

Nisio, Andrea Di, Maria Santa Rocca, Iva Šabović, et al.. (2019). Perfluorooctanoic acid alters progesterone activity in human endometrial cells and induces reproductive alterations in young women. Chemosphere. 242. 125208–125208. 61 indexed citations

Boso, Daniele, Elena Rampazzo, Carlo Zanon, et al.. (2019). HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells. Theranostics. 9(17). 4860–4877. 40 indexed citations

Zampini, Matteo, Claudia Tregnago, Valéria Bisio, et al.. (2018). Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. Leukemia. 32(5). 1124–1134. 17 indexed citations

D’Angelo, Edoardo, Carlo Zanon, Francesca Sensi, et al.. (2017). miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Journal of Clinical Pathology. 71(4). 344–350. 33 indexed citations

Agostini, Marco, Andrea Zangrando, Chiara Pastrello, et al.. (2015). A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients. Cancer Biology & Therapy. 16(8). 1160–1171. 48 indexed citations

10.

Molenaar, Remco J., Dagmar Verbaan, Simona Lamba, et al.. (2014). The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. Neuro-Oncology. 16(9). 1263–1273. 158 indexed citations

11.

Bleeker, Fonnet E., Simona Lamba, Carlo Zanon, et al.. (2014). Mutational profiling of kinases in glioblastoma. BMC Cancer. 14(1). 718–718. 50 indexed citations

12.

Riera, Ludovica, Elena Lasorsa, Lisa Bonello, et al.. (2011). Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. Leukemia & lymphoma. 52(9). 1742–1750. 11 indexed citations

13.

Bleeker, Fonnet E., Simona Lamba, Carlo Zanon, et al.. (2009). Absence of AKT1 Mutations in Glioblastoma. PLoS ONE. 4(5). e5638–e5638. 27 indexed citations

14.

Balakrishnan, Asha, Junia Y. Penachioni, Simona Lamba, et al.. (2009). Molecular profiling of the âplexinomeâ in melanoma and pancreatic cancer. Human Mutation. 30(8). 1167–1174. 38 indexed citations

15.

Buttitta, Fiamma, Simona Lamba, Luca Cardone, et al.. (2008). AKT1E17K in human solid tumours. Oncogene. 27(42). 5648–5650. 175 indexed citations

16.

Balakrishnan, Asha, Fonnet E. Bleeker, Simona Lamba, et al.. (2007). Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic Carcinoma. Cancer Research. 67(8). 3545–3550. 128 indexed citations

17.

Benvenuti, Silvia, Milo Frattini, Sabrina Arena, et al.. (2007). PIK3CAcancer mutations display gender and tissue specificity patterns. Human Mutation. 29(2). 284–288. 75 indexed citations

18.

Ruivenkamp, Claudia, Tom van Wezel, Carlo Zanon, et al.. (2002). Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nature Genetics. 31(3). 295–300. 188 indexed citations

19.

Garofano, Luciano, João Henrique G. Lago, Carlo Zanon, et al.. (1998). Italian population data on the polymarker system and on the five short tandem repeat loci CSF1PO, TPOX, TH01, F13B, and vWA.. PubMed. 43(4). 837–40. 5 indexed citations

20.

Hanotte, Olivier, et al.. (1994). Isolation and characterization of microsatellite loci in a passerine bird: the reed bunting Emberiza schoeniclus. Molecular Ecology. 3(5). 529–530. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact